Omega Fund Management, LLC Long-Term Concentrated

Location: Boston, MA

CIK: 0001637359 · Show all filings

Period: Q1 2021 (← Previous) (Next →)

Filing Date: Nov 15, 2021

Total Value: $1.057B

Holdings (24)

NUVB Nuvation Bio 27.9%

Value $295M Shares 28,212,376 Est. Cost $11.18 Unrealized 0.0%

REPL Replimune Group 14.5%

Value $153M Shares 5,008,245 Est. Cost $17.40 Unrealized +115.2%

— Morphic Holding 13.6%

Value $144M Shares 2,272,478 Est. Cost $19.82 Unrealized —

— Kronos Bio 10.6%

Value $112M Shares 3,818,283 Est. Cost $29.87 Unrealized —

— Ikena Oncology 6.0%

Value $63.54M Shares 2,249,123 Est. Cost $28.25 Unrealized —

AVIR Atea Pharmaceuticals 4.9%

Value $52.31M Shares 847,208 Est. Cost $32.23 Unrealized +109.6%

— Spruce Biosciences 3.4%

Value $35.87M Shares 2,161,022 Est. Cost $24.31 Unrealized —

GOSS Gossamer Bio 2.9%

Value $30.72M Shares 3,320,608 Est. Cost $20.85 Unrealized -51.7%

IMUX Immunic 2.7%

Value $28.5M Shares 1,788,160 Est. Cost $13.89 Unrealized +22.1%

SANA Sana Biotechnology, Inc. 2.7%

Value $28.24M Shares 843,750 Est. Cost $32.56 Unrealized 0.0%

— Paratek Pharmaceuticals 1.7%

Value $18.36M Shares 2,600,410 Est. Cost $34.18 Unrealized —

ARQT Arcutis Biothereapeutics 1.7%

Value $18.05M Shares 623,836 Est. Cost $26.87 Unrealized +16.2%

— Checkmate Pharmaceuticals 1.5%

Value $16.21M Shares 1,335,050 Est. Cost $11.51 Unrealized —

— Alpine Immune Sciences 1.3%

Value $13.62M Shares 1,284,900 Est. Cost $8.79 Unrealized —

— Syros Pharmaceuticals 1.1%

Value $11.69M Shares 1,562,500 Est. Cost $10.85 Unrealized —

— ESSA Pharma 0.9%

Value $9.786M Shares 336,869 Est. Cost $3.14 Unrealized —

— Cidara Therapeutics 0.5%

Value $5.334M Shares 2,005,249 Est. Cost $5.64 Unrealized —

— Omega Alpha SPAC 0.5%

Value $5M Shares 501,000 Est. Cost $9.98 Unrealized —

— FibroGen 0.4%

Value $4.535M Shares 130,646 Est. Cost $27.34 Unrealized —

TRVI Trevi Therapeutics 0.3%

Value $3.424M Shares 1,263,408 Est. Cost $8.20 Unrealized -64.3%

— ObsEva 0.3%

Value $3.248M Shares 999,364 Est. Cost $9.76 Unrealized —

— Jounce Therapeutics 0.3%

Value $2.83M Shares 275,513 Est. Cost $21.99 Unrealized —

IMCR Immunocore Holdings 0.2%

Value $2.194M Shares 51,535 Est. Cost $42.57 Unrealized —

— Pieris Pharmaceuticals 0.1%

Value $580K Shares 225,741 Est. Cost $1.83 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
NUVB	Nuvation Bio	28,212,376	$295M	27.9%	$11.18	0.0%	—	67080N101
REPL	Replimune Group	5,008,245	$153M	14.5%	$17.40	+115.2%	—	76029N106
—	Morphic Holding	2,272,478	$144M	13.6%	$19.82	—	—	61775R105
—	Kronos Bio	3,818,283	$112M	10.6%	$29.87	—	—	50107A104
—	Ikena Oncology	2,249,123	$63.54M	6.0%	$28.25	—	—	45175G108
AVIR	Atea Pharmaceuticals	847,208	$52.31M	4.9%	$32.23	+109.6%	—	04683R106
—	Spruce Biosciences	2,161,022	$35.87M	3.4%	$24.31	—	—	85209E109
GOSS	Gossamer Bio	3,320,608	$30.72M	2.9%	$20.85	-51.7%	—	38341P102
IMUX	Immunic	1,788,160	$28.5M	2.7%	$13.89	+22.1%	—	4525EP101
SANA	Sana Biotechnology, Inc.	843,750	$28.24M	2.7%	$32.56	0.0%	—	799566104
—	Paratek Pharmaceuticals	2,600,410	$18.36M	1.7%	$34.18	—	—	699374302
ARQT	Arcutis Biothereapeutics	623,836	$18.05M	1.7%	$26.87	+16.2%	—	03969K108
—	Checkmate Pharmaceuticals	1,335,050	$16.21M	1.5%	$11.51	—	—	162818108
—	Alpine Immune Sciences	1,284,900	$13.62M	1.3%	$8.79	—	—	02083G100
—	Syros Pharmaceuticals	1,562,500	$11.69M	1.1%	$10.85	—	—	87184Q107
—	ESSA Pharma	336,869	$9.786M	0.9%	$3.14	—	—	29668H708
—	Cidara Therapeutics	2,005,249	$5.334M	0.5%	$5.64	—	—	171757107
—	Omega Alpha SPAC	501,000	$5M	0.5%	$9.98	—	—	G6749V107
—	FibroGen	130,646	$4.535M	0.4%	$27.34	—	—	31572Q808
TRVI	Trevi Therapeutics	1,263,408	$3.424M	0.3%	$8.20	-64.3%	—	89532M101
—	ObsEva	999,364	$3.248M	0.3%	$9.76	—	—	H5861P103
—	Jounce Therapeutics	275,513	$2.83M	0.3%	$21.99	—	—	481116101
IMCR	Immunocore Holdings	51,535	$2.194M	0.2%	$42.57	—	—	45258D105
—	Pieris Pharmaceuticals	225,741	$580K	0.1%	$1.83	—	—	720795103